Both prismax and prismaflex have had ongoing multisystem device failures leading to adverse patient events, unintended blood loss, known issues with fluid removal due to scale inaccuracies, hardware and software issues, arps tubing failures, additional filter changes, lost patient treatment time and the potential additional clinician exposure to covid due to this device being used in the icu on covid patients.Baxter is aware of these issues and have demanded that employees not put anything in writing including email, instant messaging or microsoft teams messaging any device issues, in an attempt to not have an fda product recall prohibiting the sale of the prismax and prismaflex device.(b)(4).(b)(6).
|